Suppr超能文献

糖皮质激素对肾上腺和卵巢细胞中人清道夫受体 B 类 I 型基因表达的反馈抑制作用。

Feedback inhibition of human scavenger receptor class B type I gene expression by glucocorticoid in adrenal and ovarian cells.

机构信息

Department of Basic Sciences, Foundation of Research and Technology-Hellas, Heraklion 71003, Greece.

出版信息

Endocrinology. 2010 Jul;151(7):3214-24. doi: 10.1210/en.2009-1302. Epub 2010 May 12.

Abstract

Scavenger receptor class B type I (SR-BI) facilitates the reverse transport of excess cholesterol from peripheral tissues to the liver via high-density lipoproteins. In steroidogenic tissues, SR-BI supplies cholesterol for steroid hormone production. We show here that the transcription of the human SR-BI gene is subject to feedback inhibition by glucocorticoid in adrenal and ovarian cells. SR-BI mRNA levels were increased in adrenals from corticosterone-insufficient Crh(-/-) mice, whereas corticosterone replacement by oral administration inhibited SR-BI gene expression in these mice. SR-BI mRNA levels were increased in adrenals from wild-type mice treated with metyrapone, a drug that blocks corticosterone synthesis. Experiments in adrenocortical H295R and ovarian SKOV-3 cells using cycloheximide and siRNA-mediated gene silencing revealed that glucocorticoid-mediated inhibition of SR-BI gene transcription requires de novo protein synthesis and the glucocorticoid receptor (GR). No direct binding of GR to the SR-BI promoter could be demonstrated in vitro and in vivo, suggesting an indirect mechanism of repression of SR-BI gene transcription by GR in adrenal cells. Deletion analysis established that the region of the human SR-BI promoter between nucleotides -201 and -62 is sufficient to mediate repression by glucocorticoid. This region contains putative binding sites for transcriptional repressors that could play a role in SR-BI gene regulation in response to glucocorticoid. In summary, this is the first report showing that glucocorticoid suppress SR-BI expression suggesting that steroidogenic tissues maintain steroid hormone homeostasis by prohibiting SR-BI-mediated high-density lipoprotein cholesterol uptake when the endogenous levels of glucocorticoid are elevated.

摘要

清道夫受体 B 类 I 型(SR-BI)通过高密度脂蛋白促进外周组织中多余胆固醇向肝脏的逆向转运。在类固醇生成组织中,SR-BI 为类固醇激素的产生提供胆固醇。我们在这里表明,人类 SR-BI 基因的转录受到糖皮质激素在肾上腺和卵巢细胞中的反馈抑制。皮质酮不足的 Crh(-/-) 小鼠肾上腺中的 SR-BI mRNA 水平增加,而口服给予皮质酮可抑制这些小鼠的 SR-BI 基因表达。给予米托坦(一种阻断皮质酮合成的药物)的野生型小鼠的肾上腺中,SR-BI mRNA 水平增加。在使用环己酰亚胺和 siRNA 介导的基因沉默的肾上腺皮质 H295R 和卵巢 SKOV-3 细胞中的实验表明,糖皮质激素介导的 SR-BI 基因转录抑制需要新的蛋白质合成和糖皮质激素受体(GR)。在体外和体内均未证明 GR 与 SR-BI 启动子的直接结合,这表明在肾上腺细胞中,GR 通过间接机制抑制 SR-BI 基因转录。缺失分析确定,人类 SR-BI 启动子中核苷酸-201 到-62 之间的区域足以介导糖皮质激素的抑制。该区域包含转录抑制剂的可能结合位点,这些抑制剂可能在糖皮质激素对 SR-BI 基因调控中的作用。总之,这是第一个表明糖皮质激素抑制 SR-BI 表达的报告,表明类固醇生成组织通过在糖皮质激素内源性水平升高时阻止 SR-BI 介导的高密度脂蛋白胆固醇摄取,从而维持类固醇激素的体内平衡。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验